About nanoappsmedical

NanoApps Medical - Official website

From molecule to medicine via machine learning

t typically takes many years of experiments to develop a new medicine. Although vaccines to protect against disease from the novel coronavirus are starting to reach clinics around the world, patients and doctors will still need treatments to manage COVID-19 symptoms for some time. At Pacific Northwest National Laboratory (PNNL), computational biologists, structural biologists, and [...]

By |2020-12-19T12:40:13+00:00December 19th, 2020|Categories: News|0 Comments

First Optical Tweezers Capable of Trapping Nanoparticles

Optical tweezers are a rapidly growing technology, and have opened up a wide variety of research applications in recent years. The devices operate by trapping particles at the focal points of tightly focused laser beams, allowing researchers to manipulate the objects without any physical contact. So far, optical tweezers have been used to confine objects [...]

By |2020-12-15T16:04:25+00:00December 15th, 2020|Categories: News|0 Comments

Brain Implants Enable Man to Simultaneously Control Two Prosthetic Limbs with ‘Thoughts’

In what is believed to be a medical first, researchers from Johns Hopkins Medicine (JHM) and the Johns Hopkins University Applied Physics Laboratory (APL) have enabled a quadriplegic man to control a pair of prosthetic arms with his mind. In January 2019, surgeons implanted six electrodes into the brain of Robert “Buz” , during a [...]

By |2020-12-13T14:27:07+00:00December 13th, 2020|Categories: News|0 Comments

How to use antibodies to control chemical reactions

Antibodies are remarkable biomarkers: they are the cues that provide us with indications about many diseases and how our immune system counter them. Now a group of scientists from the University of Rome, Tor Vergata (Italy) has found a way to repurpose them so that they can trigger a specific chemical reaction. "We demonstrated a [...]

By |2020-12-12T12:48:45+00:00December 12th, 2020|Categories: News|0 Comments

How COVID-19 Reaches the Brain

Using post-mortem tissue samples, a team of researchers from Charité – Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune system responds to the virus once it does. The results, which show that SARS-CoV-2 enters the brain via nerve cells in [...]

By |2020-12-06T10:14:45+00:00December 6th, 2020|Categories: News|0 Comments

Medicine-carriers made from human cells can cure lung infections

Scientists used human white blood cell membranes to carry two drugs, an antibiotic and an anti-inflammatory, directly to infected lungs in mice. The nano-sized drug delivery method developed at Washington State University successfully treated both the bacterial growth and inflammation in the mice's lungs. The study, recently published in Communications Biology, shows a potential new [...]

By |2020-12-05T16:03:55+00:00December 5th, 2020|Categories: News|0 Comments

Quantum nanodiamonds may help detect disease earlier

The quantum sensing abilities of nanodiamonds can be used to improve the sensitivity of paper-based diagnostic tests, potentially allowing for earlier detection of diseases such as HIV, according to a study led by UCL researchers in the i-sense McKendry group. Paper-based lateral flow tests work the same way as a pregnancy test in that a [...]

By |2020-11-27T13:05:27+00:00November 27th, 2020|Categories: News|0 Comments

‘Nanobodies’ could hold clues to new COVID-19 therapies

WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19. Alpacas produce unique antibodies—called nanobodies—that can bind very specifically to a protein. The research team are developing nanobodies specific for the SARS-CoV-2 'spike' protein, which sticks [...]

By |2020-11-26T11:07:13+00:00November 26th, 2020|Categories: News|0 Comments

Oxford University breakthrough on global COVID-19 vaccine

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection. Our vaccine work is progressing quickly. To ensure you have the latest information or to find [...]

By |2020-11-23T08:16:06+00:00November 23rd, 2020|Categories: News|0 Comments

Altered ‘Coat’ Disguises Fatal Brain Virus From Neutralizing Antibodies

A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for this and other viral mutations may help identify patients at risk for developing a fatal brain disease. Dr. Aron Lukacher, professor and chair of the [...]

By |2020-11-23T08:11:16+00:00November 22nd, 2020|Categories: News|0 Comments
Go to Top